Associated Banc Corp Vertex Pharmaceuticals Inc Transaction History

Associated Banc Corp

  • $3.19 Billion
  • Q4 2024

A detailed history of Associated Banc Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Associated Banc Corp holds 8,828 shares of VRTX stock, worth $4.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,828
Previous 9,119 3.19%
Holding current value
$4.5 Million
Previous $4.24 Million 16.18%
% of portfolio
0.11%
Previous 0.13%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$396.64 - $516.74 $115,422 - $150,371
-291 Reduced 3.19%
8,828 $3.56 Million
Q3 2024

Nov 13, 2024
SELL
$460.0 - $505.78 $166,520 - $183,092
-362 Reduced 3.82%
9,119 $4.24 Million
Q2 2024

Aug 01, 2024
SELL
$392.81 - $485.53 $56,171 - $69,430
-143 Reduced 1.49%
9,481 $4.44 Million
Q1 2024

May 09, 2024
SELL
$407.69 - $446.08 $53,407 - $58,436
-131 Reduced 1.34%
9,624 $4.02 Million
Q4 2023

Feb 09, 2024
SELL
$343.0 - $410.68 $33,957 - $40,657
-99 Reduced 1.0%
9,755 $3.97 Million
Q3 2023

Nov 09, 2023
SELL
$338.18 - $362.46 $16,232 - $17,398
-48 Reduced 0.48%
9,854 $3.43 Million
Q2 2023

Aug 07, 2023
BUY
$314.42 - $351.91 $1,572 - $1,759
5 Added 0.05%
9,902 $3.48 Million
Q1 2023

May 09, 2023
SELL
$283.23 - $323.1 $228,566 - $260,741
-807 Reduced 7.54%
9,897 $3.12 Million
Q4 2022

Feb 10, 2023
SELL
$285.76 - $321.48 $57,723 - $64,938
-202 Reduced 1.85%
10,704 $3.09 Million
Q3 2022

Nov 09, 2022
SELL
$273.83 - $305.53 $33,133 - $36,969
-121 Reduced 1.1%
10,906 $3.16 Million
Q2 2022

Aug 10, 2022
SELL
$234.96 - $292.55 $105,262 - $131,062
-448 Reduced 3.9%
11,027 $3.11 Million
Q1 2022

May 11, 2022
SELL
$221.42 - $260.97 $2.02 Million - $2.38 Million
-9,122 Reduced 44.29%
11,475 $3 Million
Q4 2021

Feb 10, 2022
SELL
$177.01 - $223.45 $970,014 - $1.22 Million
-5,480 Reduced 21.01%
20,597 $4.52 Million
Q3 2021

Nov 08, 2021
SELL
$181.39 - $202.99 $722,294 - $808,306
-3,982 Reduced 13.25%
26,077 $4.73 Million
Q2 2021

Aug 11, 2021
BUY
$187.49 - $221.1 $4.17 Million - $4.91 Million
22,225 Added 283.7%
30,059 $6.06 Million
Q1 2021

May 05, 2021
SELL
$207.02 - $241.31 $13.6 Million - $15.9 Million
-65,697 Reduced 89.35%
7,834 $1.86 Million
Q4 2020

Feb 11, 2021
BUY
$207.01 - $276.09 $6.71 Million - $8.95 Million
32,417 Added 78.85%
73,531 $17.4 Million
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $6.05 Million - $7.18 Million
23,680 Added 135.83%
41,114 $11.2 Million
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $2.16 Million - $2.84 Million
9,595 Added 122.4%
17,434 $5.06 Million
Q1 2020

May 14, 2020
BUY
$199.77 - $247.81 $1.57 Million - $1.94 Million
7,839 New
7,839 $1.87 Million

Others Institutions Holding VRTX

# of Institutions
1,764
Shares Held
228M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $131B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Associated Banc Corp Portfolio

Follow Associated Banc Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email